Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1997 Jan;4(1):104–106. doi: 10.1128/cdli.4.1.104-106.1997

Antibody production against hepatitis C virus core and nonstructural 3 proteins is highly sensitive to deficits in T-cell function.

Y Ando 1, A Sönnerborg 1, L Barkholt 1, A Birkett 1, B G Ericzon 1, M Sällberg 1
PMCID: PMC170485  PMID: 9008291

Abstract

The influence of suppression of CD4+ and CD8+ T cells on the humoral responses to hepatitis C virus (HCV) core and nonstructural 3 proteins was studied. An increasing viral burden cannot substitute for the lack of functional T cells in maintaining humoral HCV-specific responses.

Full Text

The Full Text of this article is available as a PDF (162.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chazouilleres O., Kim M., Combs C., Ferrell L., Bacchetti P., Roberts J., Ascher N. L., Neuwald P., Wilber J., Urdea M. Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994 Apr;106(4):994–999. doi: 10.1016/0016-5085(94)90759-5. [DOI] [PubMed] [Google Scholar]
  2. Chen M., Sönnerborg A., Sällberg M. Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein. J Clin Microbiol. 1995 Mar;33(3):778–780. doi: 10.1128/jcm.33.3.778-780.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chiba J., Ohba H., Matsuura Y., Watanabe Y., Katayama T., Kikuchi S., Saito I., Miyamura T. Serodiagnosis of hepatitis C virus (HCV) infection with an HCV core protein molecularly expressed by a recombinant baculovirus. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4641–4645. doi: 10.1073/pnas.88.11.4641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cribier B., Rey D., Schmitt C., Lang J. M., Kirn A., Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS. 1995 Oct;9(10):1131–1136. doi: 10.1097/00002030-199510000-00003. [DOI] [PubMed] [Google Scholar]
  5. Diepolder H. M., Zachoval R., Hoffmann R. M., Wierenga E. A., Santantonio T., Jung M. C., Eichenlaub D., Pape G. R. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 1995 Oct 14;346(8981):1006–1007. doi: 10.1016/s0140-6736(95)91691-1. [DOI] [PubMed] [Google Scholar]
  6. Hagiwara H., Hayashi N., Mita E., Takehara T., Kasahara A., Fusamoto H., Kamada T. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology. 1993 Mar;104(3):877–883. doi: 10.1016/0016-5085(93)91025-d. [DOI] [PubMed] [Google Scholar]
  7. Jin L., Peterson D. L. Expression, isolation, and characterization of the hepatitis C virus ATPase/RNA helicase. Arch Biochem Biophys. 1995 Oct 20;323(1):47–53. doi: 10.1006/abbi.1995.0008. [DOI] [PubMed] [Google Scholar]
  8. Nasoff M. S., Zebedee S. L., Inchauspé G., Prince A. M. Identification of an immunodominant epitope within the capsid protein of hepatitis C virus. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5462–5466. doi: 10.1073/pnas.88.12.5462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Okamoto H., Tsuda F., Machida A., Munekata E., Akahane Y., Sugai Y., Mashiko K., Mitsui T., Tanaka T., Miyakawa Y. Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology. 1992 Feb;15(2):180–186. doi: 10.1002/hep.1840150203. [DOI] [PubMed] [Google Scholar]
  10. Shindo M., Di Bisceglie A. M., Cheung L., Shih J. W., Cristiano K., Feinstone S. M., Hoofnagle J. H. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. Ann Intern Med. 1991 Nov 1;115(9):700–704. doi: 10.7326/0003-4819-115-9-700. [DOI] [PubMed] [Google Scholar]
  11. Sällberg M., Rudén U., Wahren B., Magnius L. O. Antigenic regions within the hepatitis C virus envelope 1 and non-structural proteins: identification of an IgG3-restricted recognition site with the envelope 1 protein. Clin Exp Immunol. 1993 Mar;91(3):489–494. doi: 10.1111/j.1365-2249.1993.tb05929.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sällberg M., Rudén U., Wahren B., Magnius L. O. Immune response to a single peptide containing an immunodominant region of hepatitis C virus core protein: the isotypes and the recognition site. Immunol Lett. 1992 Jun;33(1):27–33. doi: 10.1016/0165-2478(92)90089-7. [DOI] [PubMed] [Google Scholar]
  13. Urushihara A., Sodeyama T., Matsumoto A., Tanaka E. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection. J Med Virol. 1994 Apr;42(4):348–356. doi: 10.1002/jmv.1890420405. [DOI] [PubMed] [Google Scholar]
  14. Yun Z. B., Lindh G., Weiland O., Johansson B., Sönnerborg A. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors. J Med Virol. 1993 Jan;39(1):57–61. doi: 10.1002/jmv.1890390111. [DOI] [PubMed] [Google Scholar]
  15. Zhang Z. X., Chen M., Sönnerborg A., Weiland O., Sällberg M. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins. J Infect Dis. 1995 May;171(5):1356–1359. doi: 10.1093/infdis/171.5.1356. [DOI] [PubMed] [Google Scholar]
  16. Zhang Z. X., Chen M., Wallhagen K., Trojnar J., Magnius L. O., Wahren B., Sällberg M. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein. Clin Exp Immunol. 1994 Jun;96(3):403–409. doi: 10.1111/j.1365-2249.1994.tb06042.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES